The current study , the FINEST Trial ( Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE ) , was designed to assess the clinical outcome of heparin-coated and standard vascular grafts in a prospective , randomized , controlled , multicenter trial .